SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (475)1/16/2003 12:09:15 PM
From: scaram(o)uche  Respond to of 1022
 
Lerner heads the SAB at Epicyte, and Epicyte is working on a topical for herpes. I therefore presume, but do not know, that..........



To: nigel bates who wrote (475)1/16/2003 12:09:55 PM
From: tuck  Respond to of 1022
 
Nigel,

Nice find. I would expect folks would be interested in licensing that technology. Worth watching. Not in PNAS early edition yet. (However, while looking, found an interesting abstract by MAXY, see that thread).

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News